Larimar Therapeutics, Inc. (LRMR) has a market capitalization of $416.77M and trades at $4.87. The 52-week range is 1.61-6.42.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.1, Earnings Per Share (EPS) of $-2.27.
The stock has a beta of 1.02, operates in the Healthcare sector.
